Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.

Acosta EP, Kendall MA, Gerber JG, Alston-Smith B, Koletar SL, Zolopa AR, Agarwala S, Child M, Bertz R, Hosey L, Haas DW
Antimicrob Agents Chemother. 2007 51 (9): 3104-10

PMID: 17576825 · PMCID: PMC2043180 · DOI:10.1128/AAC.00341-07

MeSH Terms (18)

Adolescent Adult Anti-HIV Agents Antitubercular Agents Area Under Curve Atazanavir Sulfate Biotransformation Drug Interactions Female Half-Life HIV Infections Humans Male Middle Aged Oligopeptides Pyridines Rifampin Tuberculosis

Connections (1)

This publication is referenced by other Labnodes entities:

Links